{"url_path":"/sec/inti/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1042418/0001493152-26-023622-index.html","accession_number":"0001493152-26-023622","cik":"0001042418","ticker":"INTI","issuer_name":"Inhibitor Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1042418/0001493152-26-023622-index.html","primary_entity_key":"0001042418","primary_entity_name":"Inhibitor Therapeutics, Inc."},"word_count":53,"has_tables":true,"body_markdown":"**Item\n1. Legal Proceedings**\n\n \n\nWe\nmay from time to time become a party to various legal proceedings arising in the ordinary course of business. We are not currently the\nsubject of any pending legal proceedings other than the litigation that we initiated on March 30, 2026 relating to an executed securities\npurchase agreement."}